BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

15 related articles for article (PubMed ID: 1015923)

  • 1. Incorporation of 4.5-3-H-leucine into the limbic system of ICR mice as a long-term effect of haloperidol application.
    Hackenberg P
    Psychopharmacology (Berl); 1980; 70(1):105-8. PubMed ID: 6775326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol and apomorphine differentially affect neuropeptidase activity.
    Waters SM; Konkoy CS; Davis TP
    J Pharmacol Exp Ther; 1996 Apr; 277(1):113-20. PubMed ID: 8613907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance P levels in the rat forebrain after apomorphine and haloperidol treatment.
    Janicki P; Lypko A; Szczudlik A; Libich J
    Pol J Pharmacol Pharm; 1981; 33(5):499-502. PubMed ID: 6174959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of neurotensin content elicited by neuroleptics in nucleus accumbens.
    Govoni S; Hong JS; Yang HY; Costa E
    J Pharmacol Exp Ther; 1980 Nov; 215(2):413-7. PubMed ID: 6108359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of intrahippocampal administration of dopamine or apomorphine on EEG of limbic structures in the rabbit brain.
    Smialowski A
    Pol J Pharmacol Pharm; 1976; 28(6):579-85. PubMed ID: 1012981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
    J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of apomorphine and haloperidol on the RNA content of brain structures of the rat.
    Izquierdo I; Schutz R; Prado de Carvalho L
    Arch Int Pharmacodyn Ther; 1976 Dec; 224(2):258-62. PubMed ID: 1015923
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.